Oventus Medical’s founder and CEO Dr Chris Hart held an investor briefing on 24 November, 2020 to discuss the marketing agreement with VGM & Associates – the largest sleep and respiratory support organisation in the United States.
In the briefing, Dr Hart explains how VGM will promote Oventus’ Lab in Lab program to its more than 2,500 members – durable medical equipment distributors that sell respiratory and sleep apnea devices to patients. He notes that the site and patient numbers under the agreement are significant and expected to make a large contribution to growth in CY2021.
To watch the presentation recording, click below.
Leave a Reply